The study of aging and its associated diseases is a rapidly advancing field, with cellular senescence identified as a key contributor. FOxO4-DRI, a specialized peptide, has emerged as a critical tool for researchers investigating the mechanisms behind aging and developing targeted therapies. Its unique ability to interact with cellular pathways involved in aging makes it a compound of high interest for pharmaceutical and biotechnology companies. NINGBO INNO PHARMCHEM CO.,LTD. is a leading supplier, offering high-quality FOxO4-DRI to support these vital research efforts.

FOxO4-DRI is a cell-permeable peptide that acts as an antagonist, specifically blocking the interaction between the FOXO4 transcription factor and the p53 tumor suppressor. This interaction is central to the process of cellular aging. Senescent cells, which cease to divide and accumulate in tissues with age, often exhibit altered FOXO4 and p53 activity. FOxO4-DRI's mechanism involves inducing apoptosis in these senescent cells, a process known as senolysis. By removing senescent cells, FOxO4-DRI can potentially mitigate the negative effects of aging and contribute to tissue rejuvenation.

The therapeutic implications of FOxO4-DRI are being explored across a spectrum of age-related diseases. In cardiovascular health, researchers are examining its role in improving cardiac function by clearing senescent cardiomyocytes. For neurodegenerative conditions, its potential to reduce neuroinflammation and oxidative stress associated with senescent cells is a significant area of focus. Furthermore, in the field of oncology, FOxO4-DRI is being investigated for its ability to enhance cancer treatment outcomes by targeting senescent cells that can promote tumor growth and resistance. Sourcing high-purity FOxO4-DRI (CAS 2460055-10-9) is essential for the success of these studies.

For organizations that need to buy FOxO4-DRI, partnering with a reputable manufacturer and supplier is crucial. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing premium-grade FOxO4-DRI, ensuring purity levels of over 99%. We understand the importance of consistent quality and reliable supply for ongoing research. Our competitive prices for bulk purchases make advanced research materials more accessible. As a China-based company, we leverage our manufacturing expertise to serve the global scientific community.

We invite researchers and formulators to explore our offerings and learn how NINGBO INNO PHARMCHEM CO.,LTD. can be your trusted source for FOxO4-DRI. Our team is dedicated to providing excellent customer service and technical support. Contact us today to discuss your specific needs and to obtain a quotation for your next research project, ensuring you have access to this key peptide for your age-related disease studies.